Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan.
The use of Celox, a chitosan-based haemostatic agent, for the control of massive traumatic bleeding in patients arriving at a ROLE 2 (Enhanced Care) Facility in southwestern Afghanistan is described. Twenty-one soldiers with gunshot wounds were treated with successful haemostasis in 18 at the first application and in three after further applications. Celox is an effective haemostatic agent and a useful adjunct for the treatment of massive traumatic bleeding.
Pozza
Moreno
M
aItalian Army Medical Service, Ravenna, Italy bDepartment of Cardiac Surgery, Blackpool Victoria Hospital, Blackpool, Lancashire, UK.
Millner
Russell W J
RW
D000328:Adult; D055826:Afghan Campaign 2001-; D000346:Afghanistan; D001672:Biocompatible Materials / Q000008:administration & dosage*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D048271:Chitosan / Q000008:administration & dosage*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D014948:Wounds, Gunshot / Q000188:drug therapy*; D055815:Young Adult
D001672:Biocompatible Materials; D048271:Chitosan